re: im buying more bro,
what they are saying is that the drug companies are allready screwing the patients in terms of costs of the mediciene . ie pulmozme costs 15k pa.
so there is little upside for them in terms of ramping up prices's.
what they dont factor in, is their cost of producing the drug . which accounts for less that 20% of the sale price.So its not about increasing market share with CF.its about having a far better product and a very reduced cost of goods sold.That goes stait to their bottom line .
get on the PXS website and read their investor presentations .
- Forums
- ASX - By Stock
- SNT
- bioshares 149 article
bioshares 149 article, page-12
Featured News
Add SNT (ASX) to my watchlist
|
|||||
Last
3.1¢ |
Change
0.001(3.33%) |
Mkt cap ! $40.00M |
Open | High | Low | Value | Volume |
3.0¢ | 3.1¢ | 3.0¢ | $16.17K | 538.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 366566 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.1¢ | 422617 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 366566 | 0.030 |
10 | 2265822 | 0.029 |
5 | 1574111 | 0.028 |
1 | 100000 | 0.026 |
2 | 446248 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.031 | 377163 | 3 |
0.032 | 50000 | 1 |
0.033 | 665000 | 1 |
0.034 | 160000 | 1 |
0.035 | 400000 | 1 |
Last trade - 15.57pm 06/09/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |